THELEP controlled clinical trials in lepromatous leprosy.
D000818:Animals; D002986:Clinical Trials as Topic; D002991:Clofazimine / Q000627:therapeutic use; D003622:Dapsone / Q000627:therapeutic use; D005260:Female; D006801:Humans; D007917:Leprostatic Agents / Q000627:therapeutic use*; D007918:Leprosy / Q000188:drug therapy*; D008297:Male; D051379:Mice; D011515:Prothionamide / Q000627:therapeutic use; D012293:Rifampin / Q000627:therapeutic use
D007917:Leprostatic Agents; D011515:Prothionamide; D003622:Dapsone; D002991:Clofazimine; D012293:Rifampin